CD8A and neoplasm: Following administration, SQZ-PBMC-HPV cells are expected to migrate to lymphoid organs (lymph nodes and spleen), present E6 and E7 to stimulate HPV16-specific CD8+ T cells, which could infiltrate tumors and kill HPV16-expressing tumor cells.